Export 7 results:
Author [ Keyword(Desc)] Title Year
Filters: First Letter Of Keyword is H and Author is Syrjala, Karen L  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Hematologic Neoplasms
McGregor BA, Syrjala KL, Dolan ED, Langer SL, Redman M.  2013.  The effect of pre-transplant distress on immune reconstitution among adult autologous hematopoietic cell transplantation patients.. Brain Behav Immun. 30 Suppl:S142-8.
Hematopoietic Stem Cell Transplantation
McGregor BA, Syrjala KL, Dolan ED, Langer SL, Redman M.  2013.  The effect of pre-transplant distress on immune reconstitution among adult autologous hematopoietic cell transplantation patients.. Brain Behav Immun. 30 Suppl:S142-8.
Langer SL, Kelly TH, Storer BE, Hall SP, Lucas HG, Syrjala KL.  2012.  Expressive talking among caregivers of hematopoietic stem cell transplant survivors: acceptability and concurrent subjective, objective, and physiologic indicators of emotion.. J Psychosoc Oncol. 30(3):294-315.
Syrjala KL, Artherholt SB, Kurland BF, Langer SL, Roth-Roemer S, Elrod JABroeckel, Dikmen S.  2011.  Prospective neurocognitive function over 5 years after allogeneic hematopoietic cell transplantation for cancer survivors compared with matched controls at 5 years.. J Clin Oncol. 29(17):2397-404.
Humans
McGregor BA, Syrjala KL, Dolan ED, Langer SL, Redman M.  2013.  The effect of pre-transplant distress on immune reconstitution among adult autologous hematopoietic cell transplantation patients.. Brain Behav Immun. 30 Suppl:S142-8.
Langer SL, Kelly TH, Storer BE, Hall SP, Lucas HG, Syrjala KL.  2012.  Expressive talking among caregivers of hematopoietic stem cell transplant survivors: acceptability and concurrent subjective, objective, and physiologic indicators of emotion.. J Psychosoc Oncol. 30(3):294-315.
Syrjala KL, Artherholt SB, Kurland BF, Langer SL, Roth-Roemer S, Elrod JABroeckel, Dikmen S.  2011.  Prospective neurocognitive function over 5 years after allogeneic hematopoietic cell transplantation for cancer survivors compared with matched controls at 5 years.. J Clin Oncol. 29(17):2397-404.